Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredients Mentioned With The Possibility Of Contracting Within The Framework Of The So-called Openhouse Procedure. 2026-04-07
Germany The Health Insurance Companies Aim To Conclude Discount Contracts With All Suitable Pharmaceutical Companies According To § 130a Abs. 8 Sgb V For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal Pro 2026-04-07
Denmark Market Dialogue Prior To The Tender For 24-hour Blood Pressure Monitors And Holter Devices 2026-04-07
Denmark Eu Tender For A Contract Regarding Efforts For Mental Health And Well-being For Employees In Aalborg Municipality 2026-04-07
France Supply Of Implantable And Consumable Medical Devices For Gynecology, Urology, Ophthalmology, Ent, Visceral And Digestive 2026-04-08
Germany Conclusion Not Excluding Drug Discount Agreement. According To § 130a Paragraph. 8 Sgb V Through An Openhouse Model For The Active Ingredient Golimumab (atccode According To Who 2026-04-08
Germany Conclusion Not Excluding Drug Discount Agreement. According To § 130a Paragraph. 8 Sgb V Through An Openhouse Model For The Active Ingredient Flecainide (atccode According To Who 2026-04-08
Germany The Subject Of This Publication Is The Conclusion Of Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Tocilizumab (atc Code According To Who: L04ac07). The Contract Will Be Concluded W 2026-04-08
Germany Non-excl. Medicinal Discount Agreement According To § 130a Abs. 8 Sgb V By Means Of An Open-house Model To The Active Substance Leuprorelin (atccode By Who 2026-04-09
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph. 8 Sgb V On Medicinal Products With The Active Ingredient Bimatoprost (atccode 2026-04-09
Whats app